Advertisement

Incidence and timing of recurrence of optic neuritis

  • Kyung-Ah Park
  • Sei Yeul Oh
  • Ju-Hong Min
  • Byoung Joon Kim
Neuroophthalmology
  • 41 Downloads

Abstract

Purpose

To describe the incidence and timing of recurrence in patients with optic neuritis (ON).

Methods

Medical documents of adult patients with ON were retrospectively reviewed. The incidence and timing of recurrence of an ON episode were analyzed.

Results

One hundred eleven patients with ON were included in this study. Their mean follow-up duration was 4.1 ± 3.1 years. Seven relapses occurred after intravenous methylprednisolone treatment. The estimated cumulative incidence of recurrence in either eye was 26% at 1 year, 33% at 3 years, 37% at 5 years, and 50% at 10 years after the first episode of ON. If there was no recurrence until 6 months after the first episode of ON, the next 5-year recurrence-free survival probability was 67%. If there was no recurrence until 1 year, the next 5-year survival probability was 72%. If there was no recurrence until 2 years, the next 5-year survival probability was 81%. Relapse within 1 month and the presence of neuromyelitis optica-immunoglobulin G were factors that increased the recurrence rate over time.

Conclusions

We evaluated the incidence and timing of the recurrence in patients with ON after the first episode. Lower probability of recurrence was observed in patients with longer recurrence-free follow-up period. However, monitoring for recurrence is needed even in patients with a single episode of ON due to the increasing tendency of the estimated cumulative incidence of recurrence over many years.

Keywords

Incidence Timing Recurrence Optic neuritis 

Notes

Author contribution

Involved in study concept and design: Kyung-Ah Park and Sei Yeul Oh, Sungkyunkwan University, Neuro-Ophthalmology

Involved in collecting data: Kyung-Ah Park and Sei Yeul Oh, Sungkyunkwan University, Neuro-Ophthalmology, and Ju-Hong Min and Byoung Joon Kim, Sungkyunkwan University, Neurology

Involved in analysis and interpretation of data: Kyung-Ah Park, Sungkyunkwan University, Neuro-Ophthalmology, and Ju-Hong Min and Byoung Joon Kim, Sungkyunkwan University, Neurology

Involved in critical revision of manuscript for intellectual content: Sei Yeul Oh, Sungkyunkwan University, Neuro-Ophthalmology, and Ju-Hong Min and Byoung Joon Kim, Sungkyunkwan University, Neurology

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This study was approved by the Institutional Review Board of Samsung Medical Center (Seoul, South Korea). This study was conducted in accordance with the tenets of the Declaration of Helsinki.

Informed consent

Informed consent was not obtained in this study. Identifying information about participants was not presented in this study.

References

  1. 1.
    Beck RW, Cleary PA (1993) Optic neuritis treatment trial. One-year follow-up results. Arch Ophthalmol 111:773–775CrossRefGoogle Scholar
  2. 2.
    Optic Neuritis Study Group (1991) The clinical profile of optic neuritis. Experience of the optic neuritis treatment trial. Arch Ophthalmol 109:1673–1678CrossRefGoogle Scholar
  3. 3.
    The Optic Neuritis Study Group (1997) Visual function 5 years after optic neuritis: experience of the optic neuritis treatment trial. The optic neuritis study group. Arch Ophthalmol 115:1545–1552CrossRefGoogle Scholar
  4. 4.
    Beck RW, Gal RL, Bhatti MT, Brodsky MC, Buckley EG, Chrousos GA, Corbett J, Eggenberger E, Goodwin JA, Katz B, Kaufman DI, Keltner JL, Kupersmith MJ, Miller NR, Moke PS, Nazarian S, Orengo-Nania S, Savino PJ, Shults WT, Smith CH, Trobe JD, Wall M, Xing D (2004) Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. Am J Ophthalmol 137:77–83CrossRefGoogle Scholar
  5. 5.
    Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177–189.  https://doi.org/10.1212/wnl.0000000000001729 CrossRefGoogle Scholar
  6. 6.
    Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald criteria”. Ann Neurol 58:840–846.  https://doi.org/10.1002/ana.20703 CrossRefGoogle Scholar
  7. 7.
    McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127CrossRefGoogle Scholar
  8. 8.
    Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485–1489.  https://doi.org/10.1212/01.wnl.0000216139.44259.74 CrossRefGoogle Scholar
  9. 9.
    Waschbisch A, Atiya M, Schaub C, Derfuss T, Schwab S, Lee DH, Muller M, Linker RA (2013) Aquaporin-4 antibody negative recurrent isolated optic neuritis: clinical evidence for disease heterogeneity. J Neurol Sci 331:72–75.  https://doi.org/10.1016/j.jns.2013.05.012 CrossRefGoogle Scholar
  10. 10.
    Benamer HT, Ahmed ES, Al-Din AS, Grosset DG (2009) Frequency and clinical patterns of multiple sclerosis in Arab countries: a systematic review. J Neurol Sci 278:1–4.  https://doi.org/10.1016/j.jns.2008.12.001 CrossRefGoogle Scholar
  11. 11.
    Cabre P, Heinzlef O, Merle H, Buisson GG, Bera O, Bellance R, Vernant JC, Smadja D (2001) MS and neuromyelitis optica in Martinique (French West Indies). Neurology 56:507–514CrossRefGoogle Scholar
  12. 12.
    Chopra JS, Radhakrishnan K, Sawhney BB, Pal SR, Banerjee AK (1980) Multiple sclerosis in North-West India. Acta Neurol Scand 62:312–321CrossRefGoogle Scholar
  13. 13.
    Kira J (2003) Multiple sclerosis in the Japanese population. Lancet Neurol 2:117–127CrossRefGoogle Scholar
  14. 14.
    Papais-Alvarenga RM, Miranda-Santos CM, Puccioni-Sohler M, de Almeida AM, Oliveira S, Basilio De Oliveira CA, Alvarenga H, Poser CM (2002) Optic neuromyelitis syndrome in Brazilian patients. J Neurol Neurosurg Psychiatry 73:429–435CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Ophthalmology, Samsung Medical CenterSungkyunkwan University School of MedicineSeoulRepublic of Korea
  2. 2.Department of Neurology, Samsung Medical CenterSungkyunkwan University School of MedicineSeoulRepublic of Korea

Personalised recommendations